Oncology Institute, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncology Institute, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2019 to Q3 2024.
  • Oncology Institute, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16.1M, a 7.5% increase year-over-year.
  • Oncology Institute, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$70.2M, a 6.75% increase year-over-year.
  • Oncology Institute, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$83.1M, a 54750% decline from 2022.
  • Oncology Institute, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $152K.
  • Oncology Institute, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$10.9M, a 23.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$70.2M -$16.1M +$1.31M +7.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$71.5M -$15.5M +$1.42M +8.39% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$73M -$19.9M +$10.1M +33.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$83.1M -$18.8M -$7.75M -70.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$75.3M -$17.4M -$14.7M -551% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$60.6M -$16.9M -$11.4M -210% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$49.1M -$30M -$49.3M -256% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 $152K -$11M -$851K -8.38% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1M -$2.67M +$306K +10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $697K -$5.45M -$8.66M -270% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 $9.36M $19.3M +$20.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$10.9M -$10.2M -$1.65M -19.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$9.28M -$2.98M -$563K -23.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$8.72M $3.21M +$5.82M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$14.5M -$996K -$219K -28.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$14.3M -$8.51M -$8.51M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$5.81M -$2.42M Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-14
Q2 2020 -$2.62M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-12-14
Q1 2020 -$777K Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-12-14
Q4 2019 -$2.3K* Nov 1, 2019 Dec 31, 2019 10-K/A 2021-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.